Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Gene Therapy
Recent news which mentions Gene Therapy
< Previous
1
2
3
Next >
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
May 17, 2022
Tickers
AGTC
Tags
News
Health Care
gene therapy
From
Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
May 02, 2022
Tickers
ADVM
Tags
General
Market News
ADVM
From
Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
April 28, 2022
Tickers
PFE
Tags
Market News
General
FDA
From
Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
April 25, 2022
Tickers
OCGN
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
April 21, 2022
Tags
Biotechnology
gene therapy
cell therapy
From
PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
March 16, 2022
Tickers
FOLD
Tags
Biotech
Movers
Benzinga
From
Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
BLUE
Market News
Health Care
From
Benzinga
Why Bluebird Bio Shares Are Tumbling Today
March 07, 2022
Tickers
BLUE
Tags
Biotech
Movers
Benzinga
From
Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
February 24, 2022
Tickers
ARYD
FOLD
Tags
FOLD
M&A
Market News
From
Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
Tickers
TAK
TKPHF
Tags
TAK
Health Care
gene therapy
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
Market News
General
FDA
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
gene therapy
Phase 1 Trial
Health Care
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
Market News
News
Penny Stocks
From
Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
Tags
Biotech
Benzinga
SGMO
From
Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
February 01, 2022
Tickers
SIOX
Tags
Health Care
gene therapy
Penny Stocks
From
Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
Tags
News
TSHA
Briefs
From
Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
January 27, 2022
Tickers
TSHA
Tags
Phase 2 Trial
General
Biotech
From
Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
January 25, 2022
Tickers
FBIO
MBIO
Tags
MBIO
FBIO
News
From
Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
January 18, 2022
Tickers
BLUE
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
January 13, 2022
Tickers
SRPT
Tags
Market News
Contracts
SRPT
From
Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
January 11, 2022
Tickers
BLUE
Tags
Market News
BLUE
why it's moving
From
Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
News
BMRN
Briefs
From
Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
December 21, 2021
Tickers
PFE
Tags
FDA
General
Biotech
From
Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
December 21, 2021
Tickers
ADVM
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
December 20, 2021
Tickers
BLUE
Tags
Movers
Biotech
Benzinga
From
Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
December 20, 2021
Tickers
BLUE
Tags
Market News
BLUE
News
From
Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
Tags
Small Cap
Huntington's Disease
General
From
Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
December 13, 2021
Tickers
BLUE
Tags
Biotech
Movers
Benzinga
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
gene therapy
Trading Ideas
Phase 1 Trial
From
Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
November 26, 2021
Tickers
SELB
Tags
SELB
Trading Ideas
gene therapy
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.